報價延遲最少15分鐘:2026/05/16 01:38 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
169.12 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
8.05/14.38
|
|
企業價值
42.60B
|
| 資產負債 |
|
每股賬面淨值
37.27
|
| 現金流量 |
|
現金流量率
0.09
|
| 損益表 |
|
收益
16.31B
|
|
每股收益
89.01
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry,and it serves biopharmaceutical firms, providers, payers, and policymakers. |
